- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 20, 2025 | 45.66M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $701K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $746.72K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $77.04K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $82.08K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $808.84K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.07M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $809K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.08M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $1.56K |
| Revenue | Q1 2025 · Mar 31, 2025 | $1.56K |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 21.19M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$360.63K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $617.37K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$617.25K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$617.37K |